The Latest in FDA Evaluations and Research

FDA News


Latest News from FDA News
ST. HELIER, Jersey, Sept. 4, 2014 /PRNewswire/ -- Novocure, a commercial stage oncology company, announced today that the Japanese Ministry of Health and Welfare (MHLW) has granted High Unmet Medical Need designation to the NovoTTF-100A System. This designation requires the Japanese Ph...
-- Designation of High Unmet Medical Need allows for accelerated review of regulatory submissions in Japan, the second largest medical device market in the world
Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it will be a featured presenter at the Rodman & Renshaw 16th Annual Global Investment Conference, on September 10, 2014 at the New York Palace Hotel in New York City. Management will present the company's business model and growt...
MISSISSAUGA, ON, Sept. 4, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI) a specialty pharmaceutical company with a diverse portfolio of topical and immunology products today announced that John London, the Company's President and Co-Chief Executive Officer will be providing a corpor...
NewLink Genetics Corporation (NASDAQ: NLNK) today announced that the United States Food and Drug Administration (FDA) has given permission for the Company to proceed to Phase 1 clinical trials with their Ebola vaccine candidate. This vaccine was initially developed by the Public Health...
LAUSANNE, Switzerland, September 4, 2014 /PRNewswire/ --
REDWOOD CITY, Calif., Sept. 4, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced the publication...
SUNNYVALE, Calif., Sept. 4, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that it has been named to Forbes magazine's list of the World's Most Innovative Growth Companies, reflecting companies identified by investors as innovation leaders.
MISSION VIEJO, CA--(Marketwired - September 04, 2014) -
TARRYTOWN, N.Y., Sept. 4, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has submitted a marketing authorization application for EYLEA® (aflibercept) Injection for macular edema follow...
BALLERUP, Denmark, September 4, 2014 /PRNewswire/ --
Prospect Park Capital Corp. ("Prospect Park") (TSX VENTURE: PPK.P), a capital pool company as defined under Policy 2.4 of the TSX Venture Exchange (the "Exchange"), is pleased to provide this update on the proposed respective transactions with SOK Partners LLC ("SOK") and IOI, LLC ("IO...
Prospect Park Capital Corp. ("Prospect Park") (TSX VENTURE:PPK.P), a capital pool company as defined under Policy 2.4 of the TSX Venture Exchange (the "Exchange"), is pleased to provide this update on the proposed respective transactions with SOK Partners LLC ("SOK") and IOI, LLC ("IOI...
EDISON, N.J., Sept. 3, 2014 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc. (OTCBB:CTRV), an emerging biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today it will present at two upcoming investor conferences. Contra...
RIVER EDGE, N.J., Sept. 3, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failu...
YOUNGSTOWN, Ohio, Sept. 3, 2014 /PRNewswire/ -- Pediatric Hair Solutions, a medically owned and operated head lice treatment company announced today that they are launching their first mobile head lice treatment center in the Youngstown-Pittsburgh metro area.  The goal of the new mobil...
PORTLAND, Ore., Sept. 3, 2014 /PRNewswire/ -- For use in temporarily relieving the symptoms of tinnitus, the Levo System is a personalized, neuroscience-based sound therapy.   Leveraging the brain's natural cognitive abilities, Levo identifies and maps an individual's unique sound prin...
Argo Group US Inc., a subsidiary of Argo Group International Holdings, Ltd. (NASDAQ: AGII), an international underwriter of specialty insurance and reinsurance products, announced today that it has completed an investment in Gleason Technology, a tech...
LONDON, Sept. 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, Sept. 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
DEERFIELD, Ill. and OSAKA, Japan, Sept. 3, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that judgment was entered on the jury verdict that was returned on April 7, 2014, in the...
PLEASANTON, Calif., Sept. 3, 2014 /PRNewswire/ -- For the first time a new, wearable technology promises to help medical personnel prevent pressure ulcers by monitoring patient movement and alerting caregivers when patients susceptible to pressure ulcers need to be turned.
CENTER VALLEY, PA--(Marketwired - September 03, 2014) - Aesculap Biologics, LLC, a division of Aesculap, Inc. focused on biological approaches to the repair and regeneration of diseased or damaged tissues, is pleased to announce that the first clinical study patient was implanted with ...
MIAMI, Sept. 3, 2014 /PRNewswire-iReach/ -- BioCollections Worldwide, Inc. ("BCW") announced today that it has requested all non-essential personnel in its West African Guinea-Bissau subsidiary to return home due to the Ebola outbreak. "Although we understand this outbreak is concentra...
LONDON, Sept. 3, 2014 /PRNewswire/ -- ViiV Healthcare announced today that the European Commission (EC) has granted marketing authorisation for Triumeq® (dolutegravir 50mg / abacavir 600mg / lamivudine 300mg) tablets for the treatment of HIV in adults and adolescents aged 12 years and ...
NEW YORK, Sept. 3, 2014 /PRNewswire/ -- S&P Capital IQ (MHFI) announced today that it has commenced Factual Stock Report coverage on Matinas BioPharma Holdings, Inc.
CHICAGO, Sept. 3, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Medtr...
NEW YORK, September 3, 2014 /PRNewswire/ --
-- Unlike EDC systems, Clinical Ink's SureSource® platform captures trial data electronically during the patient visit to dramatically reduce costs and development timelines
MOUNTAIN VIEW, Calif., Sept. 3, 2014 /PRNewswire/ -- Based on its recent analysis of the eClinical solutions market, Frost & Sullivan recognizes Clinical Ink with the 2014 North American eClinical Solutions Award for Entrepreneurial Company of the Year. The award recognizes Clinica...
WASHINGTON, DC--(Marketwired - September 03, 2014) - On September 17, 2014, National Disability Institute will launch the fourth annual Financial Wellness Webinar Series designed to help people living with multiple sclerosis (MS) plan for their financial futures. Expert guests with bac...
Stericycle ExpertSOLUTIONS™ (NASDAQ: SRCL) today released the findings of its Q2 2014 Stericycle Recall Index. The report found that, though the auto industry witnessed historic recall volumes in Q2, recall rates in other sectors were relatively flat or even decreased. In fact, many in...
SAN RAFAEL, CA--(Marketwired - September 03, 2014) - SafetyChain Software, leaders in food safety and quality assurance solutions that Automate, Streamline & Improve FSQA™, along with media sponsor Food Safety Tech, is excited to announce the second segment of its three-part Global Foo...
FLINT, Mich., Sept. 3, 2014 /PRNewswire/ -- Diplomat, the nation's largest independent specialty pharmacy, announced that it will be the exclusive distributor for SYNRIBO® (omacetaxine mepesuccinate) for subcutaneous injection intended for home use. On May 5, 2014, the U.S. Food and Dr...
SAN DIEGO, Sept. 3, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Halozyme's program investigating PEGPH20 (PEGylated recombinant human hyaluronidase) in combinatio...
Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patented-protected and FDA-cleared collagen product, CellerateRX®, today announced that the Company's Chief Executive Officer, Robert Lutz, Jr., is scheduled to present a...
Insmed Incorporated (NASDAQ: INSM) announces that the Company's novel inhalation technologies for the treatment of orphan pulmonary diseases will be highlighted in a variety of clinical and scientific presentations at the European Respiratory Society's (ERS) International Congress 2014...
NEW YORK, Sept. 3, 2014 /PRNewswire/ -- American Conference Institute (ACI) is pleased to announce the agenda for its 19th Annual Drug and Medical Device Litigation on December 8-10 in New York City. Agenda is now available online.
Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has hired Scott Youmans as Senior Vice President of Operations effective September 2, 2014.